ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta Т. 17, No. 2 , 2024
P. 7-9, Bibliography 6, Engl.
UDC::577.218+616-006
DOI: https://doi.org/10.15407/biotech17.02.007
COMPREHENSIVE OVERVIEW OF ADAPTOR PROTEIN RUK/CIN85 ROLES IN CANCER
1 Palladin Institute of Biochemistry of National Academy of Sciences (NASU), Kyiv, Ukraine
2 Masaryk University, Brno, the Czech Republic
Aim. This study is focused on a comprehensive overview of mechanisms and processes involved in the acquisition of cancer cell plasticity in a manner dependent on the adapter protein Ruk/CIN85 (in rodents, Ruk — the regulator of ubiquitous kinase; in human CIN85 — Cbl-interacting protein of 85 kDa, encoded by SH3KBP1 gene).
Methods. Gene expression was evaluated using RT2-PCR. Western blotting, cell proliferation and survival were analyzed using MTT and/or dye exclusion assays, motility was assessed by scratch test and Transwell assay, and enzyme activities were measured using spectrophotometric assays. In vivo metastasis were studied using experimental metastasis model.
Conclusion. This study discloses various aspects of cancer cells' plasticity, such as EMT, stemness, metabolic changes, ECM components, and drug resistance, depending on adaptor protein Ruk/CIN85 expression level.
Key words: adaptor protein Ruk/CIN85, breast cancer, lung cancer, osteosarcoma, motility,metastasis, cancer stem cells, drug resistance, cancer cell plasticity.
© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2024